Semaglutide: Which dose for which patient Part 1: Your questions answered

   Rated 5 / 5 stars

Claim CPD for this activity

Educational Activities (EA)
30 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)
30 minutes

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)
0 minutes

These are activities that use your work data to ensure quality results.

EA
30 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
30 minutes

These are activities that require reflection on feedback about your work.

MO
0 minutes

These are activities that use your work data to ensure quality results.

Listen to the episode

Description

The questions answered in this podcast are listed below.
They were compiled by GPs and health professionals around Australia.

  1. Can you start on Ozempic and up titrate to 1 milligram and then switch to Wegovy if one milligram is not enough OR is the goal to up titrate to 2.4 as it is the most effective dose, so prescribing Wegovy instead?
  2. How you can switch between Ozempic to Wegovy?
  3. How about switching from semaglutide to tirzepatide, and liraglutide and saxenda?
  4. How quickly will you increase the dose and what dose do we aim for?
  5. What are your thoughts on patients that are responding to lower doses but are being prescribed a higher dose pen and trying to micro dose with a larger pen.
  6. How long do you keep the patients on semaglutide and when do you stop?
  7. When do you even think about the intermittent use of such an agent?
  8. Can semaglutide be given for life?
  9. Can the medication be given fortnightly instead of weekly?
  10. Patients that want to re-start, will they restart at the dose they stopped at or at a lower dose?
  11. Is there a BMI target for patients with T2D?
  12. Position statement on T2D remission: When are they going to update and add in the GLP ones?
  13. Do we use the same dose or higher doses of Wegovy for adolescence?
  14. What do you think about the use of semaglutide for an adolescent with autism or an adolescent using an anti-psychotic medication such as Clozapine who needs to take it on an ongoing basis?
  15. Has the use of semaglutide increased the incidence of restrictive eating disorders?
  16. Any indication for use in women with polycystic ovarian syndrome?

 

Expert: A/Prof Ralph Audehm, General Practitioner

Host: Dr David Lim, GP and Medical Educator

Total time: 28 mins

 

Last Updated: 3 Dec, 2024

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Further your CPD learning

Based on this educational activity, complete these learning modules to gain additional CPD.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Sonia Grover

Prof Sonia Grover

Heavy Menstrual Bleeding in Adolescents

Clinical A/Prof Greg Katsoulotos

Clinical A/Prof Greg Katsoulotos

Chronic & Recurrent Cough – A Practical Approach

A/Prof Gary Leong

A/Prof Gary Leong

DKA Prevention & Diabetes in Children

A/Prof Lata Vadlamudi

A/Prof Lata Vadlamudi

Epilepsy & Menopause

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

A/Prof Ralph Audehm

expert

A/Prof Ralph Audehm

General Practitioner; Carlton Family Medical, Melbourne; Clinical Associate Professor, University of Melbourne, Department of General Practice

Recent articles

Find your area of interest

Share this

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.